JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.
Skip to content
Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings
Terence H. W. Ching , Lucia Amoroso , Calvin Bohner , Elizabeth D'Amico , Jeffrey Eilbott , Tara Entezar , Madison Fitzpatrick , Geena Fram , Rachael Grazioplene , Jamila Hokanson , Anastasia Jankovsky , Stephen A. Kichuk , Bradford Martins , Prerana Patel , Henry Schaer , Sarah Shnayder , Chelsea Witherow , Christopher Pittenger , Benjamin Kelmendi
Frontiers in Psychiatry
•
February 16, 2024
correction
•
DOI: 10.3389/fpsyt.2024.1372373 (opens in new tab)
Characteristics
Randomized
Topics
Psilocybin
Keywords
Adult psychiatry
Mental health
Non-directive support
Obsessive-compulsive disorder
Treatment
Waitlist
Psychedelic medicine
OCD Intervention
Abstract
[This corrects the article DOI: 10.3389/fpsyt.2023.1278823.].
Create a free account to bookmark articles, vote on relevance, generate your own syntheses, and join the discussion.
Related reading
Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings
Frontiers in Psychiatry
January 9, 2024
9 citations
A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive–compulsive disorder
Journal of Psychopharmacology
March 13, 2026
3 citations
Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.
EClinicalMedicine
February 1, 2023
8 citations
Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive–compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial
Frontiers in Psychiatry
April 25, 2023
27 citations
An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder.
medRxiv
October 5, 2026
For research and education, not medical advice. Talk with a clinician about your own care.
© 2026 The Consciousness Library
Support Our Mission
Choose your preferred way to support The Consciousness Library's work in advancing consciousness research.
A registered 501(c)(3) nonprofit; donations are tax-deductible in the US.
Donations are processed by Mindscape Collective, our legal entity, and may appear that way on your statement.